Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease

Published:2019-02-08 Issue:6 Volume:49 Page:664-680
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Shivaji Uday N.¹²^ORCID,Sharratt Caroline L.³⁴,Thomas Tom⁵,Smith Samuel C. L.⁶,Iacucci Marietta¹²⁶,Moran Gordon W.³⁴,Ghosh Subrata¹²⁶,Bhala Neeraj⁵⁷

Affiliation:

1. National Institute for Health Research (NIHR), Birmingham Biomedical Research Centre; Birmingham UK

2. Institute of Immunology and Immunotherapy, University of Birmingham; Birmingham UK

3. National Institute for Health Research (NIHR), Nottingham Biomedical Research Centre; Nottingham UK

4. Nottingham Digestive Diseases Centre, Nottingham University Hospitals; Nottingham UK

5. Department of Gastroenterology; University Hospitals Birmingham; Birmingham UK

6. Institute of Translational Medicine; Edgbaston UK

7. University of Birmingham; Birmingham UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15097/fullpdf

Reference123 articles.

1. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

2. Infliximab for the treatment of psoriasis in the U.K.: 9 years’ experience of infusion reactions at a single centre;Wee;Br J Dermatol,2012

3. The incidence and management of infusion reactions to infliximab: a large center experience;Cheifetz;Am J Gastroenterol,2003

4. Infliximab for Crohn’s disease in clinical practice at the Mayo Clinic: the first 100 patients;Ricart;Am J Gastroenterol,2001

5. Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn’s disease;Steenholdt;J Crohns Colitis,2012

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures;Current Drug Safety;2024-11

2. An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease;Journal of Controlled Release;2024-10

3. Modified Gegen Qinlian Decoction modulated the gut microbiome and bile acid metabolism and restored the function of goblet cells in a mouse model of ulcerative colitis;Frontiers in Immunology;2024-08-06

4. Modified Jiaoqi Powder enhances epithelial autophagy against TNF-triggered apoptosis in chronic ulcerative colitis;Phytomedicine;2024-08

5. Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3